475 results on '"Morikawa, Takanori"'
Search Results
2. Gene Rearrangement and Expression of PRKACA and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms
3. GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy
4. Laparoscopic and robot-assisted surgery for adult congenital biliary dilatation achieves favorable short-term outcomes without increasing the risk of late complications
5. Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Abdominal Metastases
6. Pancreaticoduodenectomy for pancreatic head cancer with cavernous transformation of the portal vein: a case report
7. What is the impact of zinc deficiency for pancreatectomies in patients with pancreatic ductal adenocarcinoma?
8. Prognostic value of an inflammation-based nutritional score for patients with initially unresectable pancreatic adenocarcinoma undergoing conversion surgery following chemo-/radiotherapy
9. Preceding Systemic Chemotherapy for Patients with Pancreatic Ductal Adenocarcinoma with Positive Peritoneal Cytology Provides Survival Benefit Compared with Up-Front Surgery
10. The role of bilio-pancreatic limb in nonalcoholic steatohepatitis improvement after duodenal–jejunal bypass in rats
11. Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signaling
12. Staging laparoscopy is mandatory for the treatment of pancreatic cancer to avoid missing radiologically negative metastases
13. Liver resections in patients with prior bilioenteric anastomosis are predisposed to develop organ/space surgical site infections and biliary leakage: results from a propensity score matching analysis
14. Intracholecystic papillary neoplasm arising in the cystic duct and extending into common bile duct: a case report
15. MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy
16. Prognostic impact of intraoperative peritoneal cytology after neoadjuvant therapy for potentially resectable pancreatic cancer
17. Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification
18. Probiotic-related bacteremia after major hepatectomy for biliary cancer: a report of two cases
19. A long-term survivor of metachronous liver metastases of pancreatic serous cystic neoplasm associated with von Hippel–Lindau disease
20. An integrated analysis of host- and tumor-derived markers for predicting high-grade dysplasia and associated invasive carcinoma of intraductal papillary mucinous neoplasms of the pancreas
21. Prognostic indicators in pancreatic cancer patients undergoing total pancreatectomy
22. Early postoperative drainage fluid culture positivity from contaminated bile juice is predictive of pancreatic fistula after pancreaticoduodenectomy
23. The superior approach with the stomach roll-up technique improves intraoperative outcomes and facilitates learning laparoscopic distal pancreatectomy: a comparative study between the superior and inferior approach
24. Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: a case report and literature review
25. Acute Cholecystitis
26. ASO Visual Abstract: Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-abdominal Metastases
27. Current status and therapeutic strategy of acute acalculous cholecystitis: Japanese nationwide survey in the era of the Tokyo guidelines.
28. Laparoscopic partial liver resection improves the short-term outcomes compared to open surgery for liver tumors in the posterosuperior segments
29. Combination of longitudinal pancreaticojejunostomy with coring-out of the pancreatic head (Frey procedure) and distal pancreatectomy for chronic pancreatitis
30. Lymph nodes around the posterior gastric artery: their existence, frequency, and clinical implications
31. GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype
32. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma
33. Serum Anti-p53 Antibody Can Serve as a Predictive Marker for Histological Grade of Intraductal Papillary Mucinous Neoplasms of the Pancreas
34. A case of adult undifferentiated embryonal sarcoma of the liver successfully treated with right trisectionectomy: a case report
35. Locally advanced pancreatic cancer successfully treated by distal pancreatectomy with celiac axis resection (DP-CAR) after S-1 with radiation therapy followed by gemcitabine/nab-paclitaxel therapy: a case report
36. The Possibility of IPC to Prevent Ischemic-Reperfusion Injury in Skeletal Muscle in a Rat
37. Serine/Threonine Kinase 11 Plays a Canonical Role in Malignant Progression of KRAS-Mutant and GNAS-Wild-Type Intraductal Papillary Mucinous Neoplasms of the Pancreas
38. Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer
39. Chronic Glucocorticoid Use is a Potential Risk Factor for Delayed Pancreatic Fistula after Laparoscopic Distal Pancreatectomy: A Retrospective Analysis
40. Diagnostic and Prognostic Impact of Neutrophil-to-Lymphocyte Ratio for Intraductal Papillary Mucinous Neoplasms of the Pancreas With High-Grade Dysplasia and Associated Invasive Carcinoma
41. Metastasis of ovarian cancer to the bile duct: a case report
42. Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis
43. Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection
44. Abstract A081: Molecular phenotyping and risk stratification of intraductal papillary mucinous neoplasms
45. Frey’s procedure for chronic pancreatitis improves the nutritional status of these patients
46. Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention
47. Metachronous bile duct cancers originate from primary cancer clones
48. Dependence of Molecular Diode Behaviors on Aromaticity
49. Levels of tumor markers CEA/CA 19–9 in serum and peritoneal lavage predict postoperative recurrence in patients with pancreatic cancer
50. Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.